Polyestriol phosphate: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 37: Line 37:


{{medicine-stub}}
{{medicine-stub}}
<gallery>
File:Polyestriol_phosphate.svg|Polyestriol phosphate structure
File:Estriol_phosphate_molecule_ball.png|Estriol phosphate molecule model
</gallery>

Latest revision as of 00:46, 18 February 2025

Polyestriol phosphate is a synthetic, steroidal estrogen and an estrogen ester – specifically, the 3-(dihydrogen phosphate) ester of polyestriol – which is used in medicine. It is a long-acting and water-soluble form of polyestriol.

Pharmacology[edit]

As a phosphate ester of polyestriol, polyestriol phosphate is a prodrug of polyestriol that is stored in the body and is slowly hydrolyzed into polyestriol, which is the active form. The medication has a very long duration of action when given by intramuscular injection, and a single dose has a duration of about one month.

Medical uses[edit]

Polyestriol phosphate is used in the treatment of menopausal symptoms and osteoporosis in women. It has also been used to treat prostate cancer in men.

Side effects[edit]

Side effects of polyestriol phosphate are similar to those of other estrogens and include breast tenderness, breast enlargement, nausea, headache, and fluid retention.

Pharmacokinetics[edit]

Following an intramuscular injection of polyestriol phosphate, the medication is slowly absorbed into the bloodstream and is then slowly hydrolyzed into polyestriol, which is the active form.

History[edit]

Polyestriol phosphate was first described in the literature in 1957 and was introduced for medical use by 1960.

See also[edit]











Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!